dolutegravir/lamivudine vs oxcarbazepine
Side-by-side comparison of dolutegravir/lamivudine and oxcarbazepine. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
moderate Known Drug Interaction
Anticonvulsants: Oxcarbazepine Phenytoin Phenobarbital ↓Dolutegravir Avoid coadministration with DOVATO because there are insufficient data to make dosing recommendations.
Recommendation: You should avoid taking these two medications together because there is not enough information to determine a safe dose.
Dovato
Trileptal
Dovato is a complete HIV-1 treatment that combines two medicines into one tablet. It is used for adults and adolescents who weigh at least 55 pounds.
Oxcarbazepine is a medicine used to treat seizures. It helps to control seizures in adults and children.
Dovato is used to treat HIV-1 infection in adults and adolescents (12 years and older, weighing at least 55 pounds). It can be used if you have never taken HIV-1 medicines before. It can also be used to replace your current HIV-1 medicines if your virus is under control (HIV-1 RNA less than 50 copies/mL) and you have not had treatment failure or resistance to the medicines in Dovato.
Oxcarbazepine is used to treat partial-onset seizures. These seizures start in one part of the brain. It can be used alone or with other seizure medicines.
Dovato contains two drugs: dolutegravir and lamivudine. Dolutegravir blocks HIV-1 integrase, an enzyme the virus needs to multiply. Lamivudine blocks reverse transcriptase, another enzyme HIV-1 needs to make copies of itself.
Oxcarbazepine works by reducing the electrical activity in the brain. This helps to prevent seizures. It stabilizes overexcited nerve cells.
- • Headache
- • Nausea
- • Diarrhea
- • Trouble sleeping (insomnia)
- • Tiredness (fatigue)
- • Dizziness
- • Sleepiness
- • Double vision
- • Feeling tired
- • Nausea
- Pain 1,425
- Anxiety 1,051
- Emotional Distress 1,048
- Anhedonia 942
- Chronic Kidney Disease 701
- Seizure 2,805
- Tiredness 1,607
- Feeling dizzy 1,519
- Convulsion 1,465
- Headache 1,434
If you have both HIV-1 and hepatitis B, you should be tested for hepatitis B before starting Dovato. Using Dovato can cause the hepatitis B virus to become resistant to lamivudine. Stopping Dovato can also cause a severe worsening of hepatitis B. Your liver function should be checked regularly.
This medicine can cause low sodium levels in your blood. Your doctor should check your sodium levels, especially if you take other medicines that can also lower sodium. This medicine may cause suicidal thoughts or actions. Contact your doctor right away if you have any sudden changes in mood, thoughts, or feelings.
There is a pregnancy registry to monitor outcomes in people exposed to Dovato during pregnancy. Talk to your doctor if you are pregnant or plan to become pregnant. There may be a risk of neural tube defects if dolutegravir is taken at the time of conception.
Oxcarbazepine may harm your unborn baby. Talk to your doctor if you are pregnant or plan to become pregnant. There is a pregnancy registry for women who take this medicine during pregnancy. You can enroll by calling 1-888-233-2334.
Also Compare, Nearby Drugs
Compare dolutegravir/lamivudine with
Compare oxcarbazepine with
How to Read This dolutegravir/lamivudine vs oxcarbazepine Comparison
dolutegravir/lamivudine is classified in the Integrase Inhibitor / NRTI Combination drug class, while oxcarbazepine sits within the Anticonvulsant class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, dolutegravir/lamivudine has 5,167 submissions while oxcarbazepine has 8,830. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. These two drugs have a known moderate interaction flagged in FDA labeling, attributed to oxcarbazepine lowers the amount of dolutegravir in your body, which could make your hiv treatment less effective.. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between dolutegravir/lamivudine and oxcarbazepine - always consult your physician or pharmacist first.
Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.